Breaking the PMA Bottleneck: How FDA's Class II Reclassification Accelerates Precision Oncology
Dr. Dereck Mush, MD, MBA
Vara
Operates an AI-driven mammography platform to make breast cancer screening globally accessible.
What they do
Vara provides a cloud-based software platform that integrates deep learning algorithms directly into the breast cancer screening workflow. Used by radiologists, the system automatically filters out normal mammograms so physicians can focus their attention on suspicious and complex cases.
The record
- Vertical
- Oncology
- Sub-segment
- AI-powered radiology diagnostics
- Product type
- Software as a medical device
- Stage
- Series A
- Headquarters
- Berlin, Germany
- Region
- Europe
- Founded
- 2018
- Total funding
- $11M raised
Notable investors: OMERS Ventures, Merantix, Think.Health, VI Partners.
Also in Oncology
Related on The Signal
Dr. Dereck Mush, MD, MBA
Does AI Actually Improve Radiology Accuracy? What the Prospective Trials Show in 2026
Dr. Dereck Mush, MD, MBA
The Radiopharmaceutical Infrastructure Playbook: Why Telix's FDA Approval for Pixclara Redefines Neuro-Oncology Diagnostics and Theranostics
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
Full body MRI is the fastest growing product in longevity medicine. The evidence has not caught up
Full body MRI is the fastest growing product in longevity medicine. The evidence has not caught up
Dr. Dereck Mush, MD, MBA